Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
Primary Purpose
Dysphagia, Oral Pharyngeal Cancer
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Iowa Oral Performance Instrument
Sponsored by
About this trial
This is an interventional treatment trial for Dysphagia focused on measuring dysphagia, oral pharyngeal cancer, Iowa Oral Performance Instrument (IOPI), IOPI
Eligibility Criteria
Inclusion Criteria:
- diagnosed with oral, oropharyngeal, hypopharyngeal or laryngeal cancer having non-surgical treatment with chemoradiation, or radiation therapy alone, resulting in treatment associated dysphagia.
Exclusion Criteria:
- unable to adhere to assigned therapy program due to cognitive deficits
- surgical treatment for head and neck cancer
- unable to give informed consent
Sites / Locations
- UPMC
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
Traditional Therapy Only
Traditional Therapy with IOPI
Arm Description
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Standard of care therapy plus the addition of the IOPI instrument
Outcomes
Primary Outcome Measures
Tongue Pressure Generation (i.e. Tongue Strength) in Kilopascals (kPa) Using the IOPI Device
Change in tongue strength from baseline measurements; 2nd measurement collected post treatment (approximately 8 weeks from baseline)
Secondary Outcome Measures
Airway Protection During Swallowing
Penetration-aspiration scale score of the modified barium swallow (MBS) data for small, thin liquids Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled.
Minimum 1 Maximum 8 Lower is better The score being evaluated is an absolute score at the time of collection and not the change over time.
Change Over Time of Pharyngeal Residue After Swallowing
The change in pharyngeal retention measured using the normalized residue ratio scale (NRR) is being assessed.
The NRR quantifies the amount of residue remaining in the valleculae and pyriform sinuses after a swallow as a ratio of the total area of each of these two pharyngeal spaces.
Value represents the area of space that is occupied by barium at the end of a swallow.
The change from baseline to 8 weeks is documented.
A positive change (+) is worsening of symptoms. A negative change (-) is bettering of symptoms.
Swallowing Impairment-Self Report
Patient perceived outcome measure related to their view of their swallowing problem/difficulties at that point in time.
Eating Assessment Tool (EAT-10). Minimum score 0 Maximum score 40 Higher score is worse Number reported is final overall score
Swallowing Impairment
visual analog scale related to patient perceived swallowing impairment at that point in time.
Minimum - 0 Maximum - 100 Higher is worse Score reported is the overall score at that time and not a change from baseline.
Swallowing Impairment-Objective
functional oral intake scale (FOIS) The Functional Oral Intake Scale is an ordinal scale that is used to assess the current status and meaningful change in the oral intake.
Minimum - 1 Maximum - 7 Higher is better Score reported is the overall score at that point in time and not a change from baseline.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02564887
Brief Title
Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
Official Title
Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Terminated
Why Stopped
Enrollment goals not met in efficient timeframe.
Study Start Date
January 2016 (undefined)
Primary Completion Date
January 31, 2019 (Actual)
Study Completion Date
September 6, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jonas Johnson
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Patients with head and neck cancer treated with chemoradiation, often develop a treatment associated dysphagia. The common complaint is foods sticking in the pharynx. This study seeks to test the Iowa Oral Performance Instrument (IOPI) in the management of treatment induced dysphagia following chemoradiation for oral, pharyngeal, laryngeal, hypopharyngeal cancer. This pilot study seeks to compare standard exercise therapy plus IOPI to standard exercise alone to determine if recovery is enhanced and to determine if rate of recovery is accelerated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysphagia, Oral Pharyngeal Cancer
Keywords
dysphagia, oral pharyngeal cancer, Iowa Oral Performance Instrument (IOPI), IOPI
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
26 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Traditional Therapy Only
Arm Type
Other
Arm Description
Standard of care therapy for qualifying population (with opportunity to "crossover" and be assigned to the IOPI device if so desired after initial 8 week standard of care therapy completion.
Arm Title
Traditional Therapy with IOPI
Arm Type
Experimental
Arm Description
Standard of care therapy plus the addition of the IOPI instrument
Intervention Type
Device
Intervention Name(s)
Iowa Oral Performance Instrument
Other Intervention Name(s)
IOPI
Intervention Description
the IOPI device is being used to increase tongue strength and endurance
Primary Outcome Measure Information:
Title
Tongue Pressure Generation (i.e. Tongue Strength) in Kilopascals (kPa) Using the IOPI Device
Description
Change in tongue strength from baseline measurements; 2nd measurement collected post treatment (approximately 8 weeks from baseline)
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Airway Protection During Swallowing
Description
Penetration-aspiration scale score of the modified barium swallow (MBS) data for small, thin liquids Scores are determined primarily by the depth to which material passes in the airway and by whether or not material entering the airway is expelled.
Minimum 1 Maximum 8 Lower is better The score being evaluated is an absolute score at the time of collection and not the change over time.
Time Frame
8 week
Title
Change Over Time of Pharyngeal Residue After Swallowing
Description
The change in pharyngeal retention measured using the normalized residue ratio scale (NRR) is being assessed.
The NRR quantifies the amount of residue remaining in the valleculae and pyriform sinuses after a swallow as a ratio of the total area of each of these two pharyngeal spaces.
Value represents the area of space that is occupied by barium at the end of a swallow.
The change from baseline to 8 weeks is documented.
A positive change (+) is worsening of symptoms. A negative change (-) is bettering of symptoms.
Time Frame
8 week
Title
Swallowing Impairment-Self Report
Description
Patient perceived outcome measure related to their view of their swallowing problem/difficulties at that point in time.
Eating Assessment Tool (EAT-10). Minimum score 0 Maximum score 40 Higher score is worse Number reported is final overall score
Time Frame
8 week
Title
Swallowing Impairment
Description
visual analog scale related to patient perceived swallowing impairment at that point in time.
Minimum - 0 Maximum - 100 Higher is worse Score reported is the overall score at that time and not a change from baseline.
Time Frame
8 week
Title
Swallowing Impairment-Objective
Description
functional oral intake scale (FOIS) The Functional Oral Intake Scale is an ordinal scale that is used to assess the current status and meaningful change in the oral intake.
Minimum - 1 Maximum - 7 Higher is better Score reported is the overall score at that point in time and not a change from baseline.
Time Frame
8 week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
diagnosed with oral, oropharyngeal, hypopharyngeal or laryngeal cancer having non-surgical treatment with chemoradiation, or radiation therapy alone, resulting in treatment associated dysphagia.
Exclusion Criteria:
unable to adhere to assigned therapy program due to cognitive deficits
surgical treatment for head and neck cancer
unable to give informed consent
Facility Information:
Facility Name
UPMC
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
We'll reach out to this number within 24 hrs